These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 403563)

  • 1. Effect of tryptamine antagonists on self-stimulation. Interaction with amphetamine.
    Silveira Filho NG; Graeff FG
    Psychopharmacology (Berl); 1977 Mar; 52(1):87-92. PubMed ID: 403563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of minor tranquilizers, tryptamine antagonists and amphetamine on behavior punished by brain stimulation.
    Morato de Carvalho S; de Aguiar JC; Graeff FG
    Pharmacol Biochem Behav; 1981 Sep; 15(3):351-6. PubMed ID: 6117081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5HT blockade and the stimulant effects of D- and L-amphetamine: no interaction in self-stimulation of prefrontal cortex, hypothalamus, or dorsal tegmentum. unexpected lethality in hippocampal sites.
    Franklin KB; Robertson A
    Pharmacol Biochem Behav; 1980 Sep; 13(3):365-70. PubMed ID: 7422692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-stimulation of the subfornical organ and lateral hypothalamus: differential effects of atropine and methysergide.
    Robertson A; Kucharczyk J; Mogenson GJ
    Pharmacol Biochem Behav; 1977 Aug; 7(2):173-6. PubMed ID: 918139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 6. Indoleamine antagonists: relative potencies as inhibitors of tryptamine- and 5-hydroxytryptophan-evoked responses.
    Clineschmidt BV; Lotti VJ
    Br J Pharmacol; 1974 Feb; 50(2):311-3. PubMed ID: 4547673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for an indoleamine other than 5-hydroxytryptamine in the hypothalamic thermoregulatory pathways of the rat.
    Cox B; Davis A; Juxon V; Lee TF; Martin D
    J Physiol; 1983 Apr; 337():441-50. PubMed ID: 6875941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute and chronic fenfluramine on self-stimulation and its facilitation by amphetamine.
    Olds ME; Yuwiler A
    Eur J Pharmacol; 1992 Jun; 216(3):363-72. PubMed ID: 1425928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cyproheptadine and combinations of cyproheptadine and amphetamine on intermittently reinforced lever-pressing in rats.
    Graeff FG
    Psychopharmacology (Berl); 1976 Oct; 50(1):65-71. PubMed ID: 827764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptors involved in the action of 5-HT and tryptamine on the isolated rat stomach fundus preparation.
    Frankhuijzen AL; Bonta IL
    Eur J Pharmacol; 1974 May; 26(2):220-30. PubMed ID: 4854042
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of the periaqueductal gray substance in the antianxiety action of benzodiazepines.
    Schenberg LC; Graeff FG
    Pharmacol Biochem Behav; 1978 Sep; 9(3):287-95. PubMed ID: 568804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of putative 5-hydroxytryptamine receptor active agents on D-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions.
    Leccese AP; Lyness WH
    Brain Res; 1984 Jun; 303(1):153-62. PubMed ID: 6610461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of somatostatin on self-stimulation behavior in atropine- and methysergide-pretreated rats.
    Vécsei L; Schwarzberg H; Telegdy G
    Eur J Pharmacol; 1983 Jul; 91(1):89-93. PubMed ID: 6137393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hypoglycemia-induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide.
    Bivens CH; Lebovitz HE; Feldman JM
    N Engl J Med; 1973 Aug; 289(5):236-9. PubMed ID: 4713762
    [No Abstract]   [Full Text] [Related]  

  • 16. Cocaine cue in rats as it relates to subjective drug effects: a preliminary report.
    Colpaert FC; Niemegeers CJ; Janssen PA
    Eur J Pharmacol; 1976 Nov; 40(1):195-9. PubMed ID: 991926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic mechanisms in the hypothalamus mediate thermoregulatory responses in rats.
    Lin MT; Wu JJ; Tsay BL
    Naunyn Schmiedebergs Arch Pharmacol; 1983 May; 322(4):271-8. PubMed ID: 6866135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.
    Olds ME
    Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial reward after Lilly 110140 (fluoxetine HCl): evidence for an inhibitory role for serotonin.
    Katz RJ; Carroll BJ
    Psychopharmacology (Berl); 1977 Jan; 51(2):189-93. PubMed ID: 402672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of d- versus l-amphetamine, food deprivation, and current intensity on self-stimulation of the lateral hypothalamus, substantia nigra, and medial frontal cortex of the rat.
    Goodall EB; Carey RJ
    J Comp Physiol Psychol; 1975 Nov; 89(9):1029-45. PubMed ID: 1202097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.